UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000050944
Receipt number R000058068
Scientific Title Effectiveness of Telemonitoring-based Telenursing on Health Outcomes for People with Lung Cancer and Its Relations to Their Health Management Process: A Mixed Methods Research with Randomized Controlled Trial
Date of disclosure of the study information 2023/04/27
Last modified on 2025/04/30 09:02:37

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effectiveness of Telemonitoring-based Telenursing on Health Outcomes for People with Lung Cancer and Its Relations to Their Health Management Process: A Mixed Methods Research with Randomized Controlled Trial

Acronym

Telemonitoring-based Telenursing for People with Lung Cancer: A Mixed Methods Research with Randomized Controlled Trial

Scientific Title

Effectiveness of Telemonitoring-based Telenursing on Health Outcomes for People with Lung Cancer and Its Relations to Their Health Management Process: A Mixed Methods Research with Randomized Controlled Trial

Scientific Title:Acronym

Telemonitoring-based Telenursing for People with Lung Cancer: A Mixed Methods Research with Randomized Controlled Trial

Region

Japan


Condition

Condition

lung cancer

Classification by specialty

Nursing

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

A randomized controlled trial is conducted to examine the effectiveness of telemonitoring-based telenursing for people with lung cancer, as well as to understand participants' qualitative health management process and to examine whether these quantitative and qualitative outcomes are related using mixed research methods.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Percentage of detection of signs of deteriorating health conditions.

Key secondary outcomes

number of detection of signs of deteriorating health conditions, unscheduled clinic visits, Unscheduled hospitalization, quality of life, symptoms


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

NO

Dynamic allocation


Institution consideration


Blocking

YES

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Behavior,custom

Interventions/Control_1

Subjects will enter the daily vital signs, symptoms, and other medical interview items into a tablet terminal, and send it to the nursing monitoring center, and nurses will monitor the received data, triage of physical and psychological conditions, and provide nursing consultation or guidance and telementoring for three months.

Interventions/Control_2

Receive only conventional face-to-face care. Distribution of self-health record booklets

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

60 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Outpatients with lung cancer who are undergoing chemotherapy or within one year of chemotherapy
2) Those who have been diagnosed with lung cancer and are accepting treatment
3) Those who receive regular medical care from a physician and have the consent of the physician in charge to participate in this study
4) Performance Status Score: 0-2
5) Persons who are able to take daily vital signs and other measurements and answer the questionnaire items, and who can understand the operation of the terminal.

Key exclusion criteria

Persons who meet any of the following criteria
1) End-of-life
2) Patients with cognitive decline who have difficulty in self-care and verbal communication
3) Patients who require hospitalization for lung cancer during the intervention period.
4)Persons who do not understand the operation of the terminal and have no alternative

Target sample size

28


Research contact person

Name of lead principal investigator

1st name Tomoyo
Middle name
Last name Harada

Organization

St. Luke's International University

Division name

Graduate School of Nursing Science

Zip code

1040044

Address

10-1, Akashi-chou, Chuo-ku, Tokyo

TEL

03-5550-2362

Email

21dn010@slcn.ac.jp


Public contact

Name of contact person

1st name Tomoyo
Middle name
Last name Harada

Organization

St. Luke's International University

Division name

Graduate School of Nursing Science

Zip code

1040044

Address

10-1, Akashi-chou, Chuo-ku, Tokyo

TEL

03-5550-2362

Homepage URL


Email

21dn010@slcn.ac.jp


Sponsor or person

Institute

St. Luke's International University

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology Japan

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee of St. Luke's International University

Address

10-1, Akashi-chou, Chuo-ku, Tokyo

Tel

03-5550-2423

Email

kenkyukikaku@luke.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 04 Month 27 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2023 Year 04 Month 27 Day

Date of IRB

2024 Year 01 Month 09 Day

Anticipated trial start date

2024 Year 03 Month 06 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 04 Month 27 Day

Last modified on

2025 Year 04 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000058068